Renovaro Biosciences (RENB) has released an update.
Renovaro Inc. has successfully secured $3 million in additional equity financing, with the transaction set to finalize on February 20, 2024. This financial boost represents a significant vote of confidence from investors, signaling potential growth and stability for the company’s future in the stock market.
For further insights into RENB stock, check out TipRanks’ Stock Analysis page.
